Citadel Advisors Portfolio holdings
Citadel Advisors, founded in 1990 by Kenneth C. Griffin as Citadel LLC and headquartered in Chicago, Illinois, is one of the world’s most prominent hedge funds, managing tens of billions in assets through sophisticated quantitative trading strategies. The firm excels in market-making and high-frequency trading across asset classes like equities, fixed income, options, and commodities, leveraging cutting-edge technology and data analysis to generate returns. Citadel operates two main arms: its hedge fund business, which serves institutional and high-net-worth investors, and Citadel Securities, a leading market maker that facilitates a significant portion of U.S. equity and options trades. Known for its secretive, high-performance culture, Citadel has grown into a financial titan under Griffin’s leadership, influencing global markets with its scale and innovation.
Top Buys
| 1 |
NVIDIA
NVDA
|
+$1.03B |
| 2 |
Microsoft
MSFT
|
+$928M |
| 3 |
McDonald's
MCD
|
+$762M |
| 4 |
Amazon
AMZN
|
+$716M |
| 5 |
Coca-Cola
KO
|
+$650M |
Top Sells
| 1 |
Charles Schwab
SCHW
|
+$1.78B |
| 2 |
Invesco QQQ Trust
QQQ
|
+$1.22B |
| 3 |
Strategy Inc Common Stock Class A
MSTR
|
+$625M |
| 4 |
Kroger
KR
|
+$547M |
| 5 |
Danaher
DHR
|
+$504M |
Sector Composition
| 1 | Technology | 16.69% |
| 2 | Healthcare | 16.07% |
| 3 | Consumer Discretionary | 12.79% |
| 4 | Financials | 12.71% |
| 5 | Industrials | 9.58% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
MSTX
1951
Tidal Trust II Defiance Daily Target 2x Long MSTR ETF
MSTX
$715M
| $4.63M | ﹤0.01% |
114,633
+93,772
| +450% | +$3.78M |
|
1952
Liquidia Corp
LQDA
$2.2B
| $4.62M | ﹤0.01% |
370,951
-135,607
| -27% | -$1.69M |
|
1953
Diebold Nixdorf
DBD
$2.2B
| $4.62M | ﹤0.01% |
+83,379
| New | +$4.62M |
|
1954
Estee Lauder
EL
$31.2B
| $4.62M | ﹤0.01% |
57,167
-1,723,563
| -97% | -$139M |
|
1955
ConocoPhillips
COP
$115B
| $4.61M | ﹤0.01% |
+51,402
| New | +$4.61M |
|
1956
Heron Therapeutics
HRTX
$190M
| $4.6M | ﹤0.01% |
2,221,837
+1,720,347
| +343% | +$3.56M |
|
|
STKL
1957
SunOpta
STKL
$749M
| $4.6M | ﹤0.01% |
792,920
+423,229
| +114% | +$2.45M |
|
1958
Zegna
ZGN
$2.31B
| $4.59M | ﹤0.01% |
537,069
+138,571
| +35% | +$1.18M |
|
1959
Endava
DAVA
$525M
| $4.59M | ﹤0.01% |
299,625
-589,830
| -66% | -$9.04M |
|
|
JBTM
1960
JBT Marel Corporation
JBTM
$7.24B
| $4.59M | ﹤0.01% |
38,169
+33,787
| +771% | +$4.06M |
|
|
CLBR
1961
DELISTED
Colombier Acquisition Corp II
CLBR
| $4.59M | ﹤0.01% |
+296,882
| New | +$4.59M |
|
1962
New Oriental
EDU
$8.71B
| $4.59M | ﹤0.01% |
85,032
-57,743
| -40% | -$3.12M |
|
1963
Central Garden & Pet Class A
CENTA
$2.01B
| $4.58M | ﹤0.01% |
146,468
+77,861
| +113% | +$2.44M |
|
1964
PACS Group
PACS
$1.56B
| $4.58M | ﹤0.01% |
354,463
+293,393
| +480% | +$3.79M |
|
1965
Alliant Energy
LNT
$16.7B
| $4.58M | ﹤0.01% |
75,695
+74,065
| +4,544% | +$4.48M |
|
1966
Astrana Health
ASTH
$1.37B
| $4.58M | ﹤0.01% |
183,890
-96,409
| -34% | -$2.4M |
|
1967
Day One Biopharmaceuticals
DAWN
$734M
| $4.57M | ﹤0.01% |
703,644
-635,374
| -47% | -$4.13M |
|
1968
Biohaven
BHVN
$1.45B
| $4.56M | ﹤0.01% |
323,351
-904,022
| -74% | -$12.8M |
|
1969
BGC Group
BGC
$4.78B
| $4.56M | ﹤0.01% |
445,753
-857,507
| -66% | -$8.77M |
|
1970
CG Oncology
CGON
$2.6B
| $4.56M | ﹤0.01% |
175,253
-963,665
| -85% | -$25.1M |
|
1971
iShares Core International Aggregate Bond Fund
IAGG
$11B
| $4.55M | ﹤0.01% |
+89,000
| New | +$4.55M |
|
1972
Pricesmart
PSMT
$3.56B
| $4.55M | ﹤0.01% |
43,284
-35,067
| -45% | -$3.68M |
|
1973
FTAI Infrastructure
FIP
$543M
| $4.54M | ﹤0.01% |
736,019
+268,955
| +58% | +$1.66M |
|
1974
Rogers Corp
ROG
$1.48B
| $4.54M | ﹤0.01% |
66,239
-9,865
| -13% | -$676K |
|
1975
United Microelectronic
UMC
$17.2B
| $4.54M | ﹤0.01% |
592,879
-2,011,139
| -77% | -$15.4M |
|